当前位置：
X-MOL 学术
›
J. Med. Chem.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Identification and Development of a New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[11C]methoxyphenyl)-5-((1-methyl-1H-pyrazol-3-yl)methoxy)picolinamide for Imaging Metabotropic Glutamate Receptor Subtype 2 (mGlu2).
Journal of Medicinal Chemistry ( IF 6.8 ) Pub Date : 2020-09-22 , DOI: 10.1021/acs.jmedchem.9b01991 Tomoteru Yamasaki 1 , Xiaofei Zhang 2 , Katsushi Kumata 1 , Yiding Zhang 1 , Xiaoyun Deng 2 , Masayuki Fujinaga 1 , Zhen Chen 2 , Wakana Mori 1 , Kuan Hu 1 , Hidekatsu Wakizaka 1 , Akiko Hatori 1 , Lin Xie 1 , Masanao Ogawa 1, 3 , Nobuki Nengaki 1, 3 , Richard Van 4 , Yihan Shao 4 , Douglas J Sheffler 5 , Nicholas D P Cosford 5 , Steven H Liang 2 , Ming-Rong Zhang 1
Journal of Medicinal Chemistry ( IF 6.8 ) Pub Date : 2020-09-22 , DOI: 10.1021/acs.jmedchem.9b01991 Tomoteru Yamasaki 1 , Xiaofei Zhang 2 , Katsushi Kumata 1 , Yiding Zhang 1 , Xiaoyun Deng 2 , Masayuki Fujinaga 1 , Zhen Chen 2 , Wakana Mori 1 , Kuan Hu 1 , Hidekatsu Wakizaka 1 , Akiko Hatori 1 , Lin Xie 1 , Masanao Ogawa 1, 3 , Nobuki Nengaki 1, 3 , Richard Van 4 , Yihan Shao 4 , Douglas J Sheffler 5 , Nicholas D P Cosford 5 , Steven H Liang 2 , Ming-Rong Zhang 1
Affiliation
|
Metabotropic glutamate receptor 2 (mGlu2) is a known target for treating several central nervous system (CNS) disorders. To develop a viable positron emission tomography (PET) ligand for mGlu2, we identified new candidates 5a–i that are potent negative allosteric modulators (NAMs) of mGlu2. Among these candidates, 4-(2-fluoro-4-methoxyphenyl)-5-((1-methyl-1H-pyrazol-3-yl)methoxy)picolinamide (5i, also named as [11C]MG2-1812) exhibited high potency, high subtype selectivity, and favorable lipophilicity. Compound 5i was labeled with positron-emitting carbon-11 (11C) to obtain [11C]5i in high radiochemical yield and high molar activity by O-[11C]methylation of the phenol precursor 12 with [11C]CH3I. In vitro autoradiography with [11C]5i showed heterogeneous radioactive accumulation in the brain tissue sections, ranked in the order: cortex > striatum > hippocampus > cerebellum ≫ thalamus > pons. PET study of [11C]5i indicated in vivo specific binding of mGlu2 in the rat brain. Based on the [11C]5i scaffold, further optimization for new candidates is underway to identify a more suitable ligand for imaging mGlu2.
中文翻译：
用于成像代谢型谷氨酸受体亚型的新型正电子发射断层扫描配体 4-(2-氟-4-[11C]甲氧基苯基)-5-((1-甲基-1H-吡唑-3-基)甲氧基)吡啶甲酰胺的鉴定和开发2 (mGlu2)。
代谢型谷氨酸受体 2 (mGlu 2 ) 是治疗多种中枢神经系统 (CNS) 疾病的已知靶点。为了为 mGlu 2开发可行的正电子发射断层扫描 (PET) 配体，我们确定了新的候选物5a – i，它们是 mGlu 2 的有效负变构调节剂 (NAM) 。在这些候选物中，4-(2-氟-4-甲氧基苯基)-5-((1-甲基-1H-吡唑-3-基)甲氧基)吡啶甲酰胺( 5i，也称为[ 11 C]MG2-1812)表现出高效力、高亚型选择性和良好的亲脂性。化合物5i用正电子发射碳11 ( 11 C)标记得到[11 C] 5i具有高放射化学产率和高摩尔活性，通过苯酚前体12与 [ 11 C]CH 3 I的O -[ 11 C] 甲基化。[ 11 C] 5i 的体外放射自显影显示大脑中的异质放射性积累组织切片，按顺序排列：皮质>纹状体>海马>小脑≫丘脑>脑桥。[ 11 C] 5i 的PET 研究表明mGlu 2在大鼠脑中的体内特异性结合。基于[ 11 C] 5i支架上，正在对新候选物进行进一步优化，以确定更适合 mGlu 成像的配体2。
更新日期：2020-10-22
中文翻译：
用于成像代谢型谷氨酸受体亚型的新型正电子发射断层扫描配体 4-(2-氟-4-[11C]甲氧基苯基)-5-((1-甲基-1H-吡唑-3-基)甲氧基)吡啶甲酰胺的鉴定和开发2 (mGlu2)。
代谢型谷氨酸受体 2 (mGlu 2 ) 是治疗多种中枢神经系统 (CNS) 疾病的已知靶点。为了为 mGlu 2开发可行的正电子发射断层扫描 (PET) 配体，我们确定了新的候选物5a – i，它们是 mGlu 2 的有效负变构调节剂 (NAM) 。在这些候选物中，4-(2-氟-4-甲氧基苯基)-5-((1-甲基-1H-吡唑-3-基)甲氧基)吡啶甲酰胺( 5i，也称为[ 11 C]MG2-1812)表现出高效力、高亚型选择性和良好的亲脂性。化合物5i用正电子发射碳11 ( 11 C)标记得到[11 C] 5i具有高放射化学产率和高摩尔活性，通过苯酚前体12与 [ 11 C]CH 3 I的O -[ 11 C] 甲基化。[ 11 C] 5i 的体外放射自显影显示大脑中的异质放射性积累组织切片，按顺序排列：皮质>纹状体>海马>小脑≫丘脑>脑桥。[ 11 C] 5i 的PET 研究表明mGlu 2在大鼠脑中的体内特异性结合。基于[ 11 C] 5i支架上，正在对新候选物进行进一步优化，以确定更适合 mGlu 成像的配体2。
京公网安备 11010802027423号